These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27553750)

  • 21. Effect of carbamazepine and valproate on bone mineral density.
    Ecevit C; Aydoğan A; Kavakli T; Altinöz S
    Pediatr Neurol; 2004 Oct; 31(4):279-82. PubMed ID: 15464641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
    Kafali G; Erselcan T; Tanzer F
    Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired bone and muscle development in young people treated with antiepileptic drugs.
    Simm PJ; Seah S; Gorelik A; Gilbert L; Nuguid J; Werther GA; Mackay MT; Freeman JL; Petty SJ; Wark JD
    Epilepsia; 2017 Nov; 58(11):1931-1938. PubMed ID: 28880998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
    Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
    Koo DL; Nam H
    Epilepsia; 2020 Oct; 61(10):2142-2149. PubMed ID: 32944954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antiepileptic drugs on bone density in ambulatory patients.
    Farhat G; Yamout B; Mikati MA; Demirjian S; Sawaya R; El-Hajj Fuleihan G
    Neurology; 2002 May; 58(9):1348-53. PubMed ID: 12011279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drug-induced osteopenia in ambulatory epileptic children receiving a standard vitamin D3 supplement.
    Tekgul H; Dizdarer G; Demir N; Ozturk C; Tutuncuoglu S
    J Pediatr Endocrinol Metab; 2005 Jun; 18(6):585-8. PubMed ID: 16042326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy.
    Artemiadis AK; Lambrinoudaki I; Voskou P; Tsivgoulis G; Safouris A; Bougea A; Giannopoulos S; Gatzonis S; Triantafyllou N
    Epilepsy Behav; 2016 Feb; 55():84-6. PubMed ID: 26773675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.
    Cramer JA; Wang ZJ; Chang E; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy.
    Kulak CA; Borba VZ; Silvado CE; Paola Ld; Seibel MJ; Bilezikian JP; Boguszewski CL
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):466-71. PubMed ID: 17546247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs.
    Pack AM; Olarte LS; Morrell MJ; Flaster E; Resor SR; Shane E
    Epilepsy Behav; 2003 Apr; 4(2):169-74. PubMed ID: 12697142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effects of antiepileptic drugs on bone mineral density in children.
    Gissel T; Poulsen CS; Vestergaard P
    Expert Opin Drug Saf; 2007 May; 6(3):267-78. PubMed ID: 17480176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density in adult patients treated with various antiepileptic drugs.
    Beniczky SA; Viken J; Jensen LT; Andersen NB
    Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone health in people with epilepsy: is it impaired and what are the risk factors?
    Pack A
    Seizure; 2008 Mar; 17(2):181-6. PubMed ID: 18187347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone.
    Mikati MA; Dib L; Yamout B; Sawaya R; Rahi AC; Fuleihan Gel-H
    Neurology; 2006 Dec; 67(11):2005-14. PubMed ID: 17159108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.